near-significantp = 0.06
ETV demonstrated superior clinical success (RR = 1.25; 95% CI: 1.10–1.42; p < 0.001; NNT = 8) and a near-significant reduction in complications (RD = –0.05; 95% CI: –0.10 to 0.00; p = 0.06).
ETV demonstrated superior clinical success (RR = 1.25; 95% CI: 1.10–1.42; p < 0.001; NNT = 8) and a near-significant reduction in complications (RD = –0.05; 95% CI: –0.10 to 0.00; p = 0.06).
Conclusions: The analysis suggests a decreasing trend, more pronounced in the post-pandemic period, which may be attributed to reduced notification efficiency during this period and a decline in the number of births.
A notable trend is the integration of contextual information, such as patient well-being, body position, and physical activity alongside ICP.
There has been an increasing trend in publications related to VP shunt infection in pediatrics, with an annual growth rate of 5.57%.
Although point estimates suggested a potentially elevated risk of mortality (RR 2.87; 95% CI 0.60-13.80; I2 = 90.6%), intracranial hemorrhage (RR 2.09; 95% CI 0.22-19.39; I2 = 69%), and infections (RR 2.23; 95% CI 0.17-29.08; I2 = 69.5%) in the ETV group, these findings did not reach statistical significance and exhibited substantial heterogeneity.